The first Nurix Therapeutics trade was made in Q1 2022.
Since then Jim Simons bought shares nine more times and sold shares on eight occasions. The investor sold all their shares in Q2 2026 and doesn't own any shares in Nurix Therapeutics anymore.
Avg closing price
Price range
Sold -118k shares
Q2 2026
Avg closing price
$17.04
Price range
$14.64
-
$24.26
New holding (+118k shares)
Q1 2026
Avg closing price
$17.31
Price range
$14.43
-
$19.59
Sold -185k shares
Q4 2025
Avg closing price
$14.41
Price range
$9.08
-
$21.47
Increased shares by 743.8% (+163k shares)
Q3 2025
Avg closing price
$10.40
Price range
$8.24
-
$13.18
Sold 63.2% shares (-37.6k shares)
Q2 2025
Avg closing price
$10.79
Price range
$8.81
-
$12.79
New holding (+59.5k shares)
Q1 2025
Avg closing price
$16.82
Price range
$11.88
-
$20.15
Sold -246k shares
Q4 2024
Avg closing price
$22.78
Price range
$18.64
-
$28.14
Sold 24.0% shares (-77.6k shares)
Q3 2024
Avg closing price
$22.22
Price range
$18.93
-
$25.69
Increased shares by 80.7% (+145k shares)
Q2 2024
Avg closing price
$15.57
Price range
$12.02
-
$21.30
Increased shares by 55.6% (+64.1k shares)
Q1 2024
Avg closing price
$10.76
Price range
$7.77
-
$15.66
Increased shares by 329.9% (+88.4k shares)
Q4 2023